In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.
Biovault Insights
specialist knowledge, industry news & future forecasts
in human tissue and stem cell products and therapies